Table 6.

Logistic Regression Analysis for Aldosterone Within Normal Range at Visit 1 and New Use of Lipid‐Lowering Therapy at Visit 2

Outcome (Total N/New Event N)	OR (95% CI) Per 1 SD Increase in log Aldo	P Value	OR (95% CI) Top Tertile vs Bottom 2 Tertiles of Aldo	P Value
New lipid‐lowering therapy (N=808/136)
Age, sex, BMI (base)	1.24 (1.03, 1.50)	0.022	1.61 (1.09, 2.37)	0.017
Base+GFR	1.26 (1.04, 1.53)	0.017	1.67 (1.12, 2.49)	0.013
Base+antihypertensives	1.17 (0.97, 1.41)	0.103	1.45 (0.97, 2.16)	0.069
Base+smoking	1.24 (1.03, 1.50)	0.022	1.61 (1.09, 2.38)	0.016
Base+coronary artery disease	1.28 (1.06, 1.55)	0.010	1.73 (1.16, 2.57)	0.007
Base+heart failure	1.24 (1.03, 1.50)	0.022	1.61 (1.09, 2.38)	0.017
Base+myocardial infarction	1.24 (1.03, 1.49)	0.023	1.60 (1.09, 2.37)	0.018
Base+stroke	1.24 (1.03, 1.50)	0.021	1.61 (1.09, 2.37)	0.017
Base+Type 2 diabetes	1.27 (1.05, 1.53)	0.013	1.66 (1.11, 2.64)	0.013
Base+central obesity	1.26 (1.04, 1.52)	0.016	1.64 (1.11, 2.43)	0.013
Base+blood pressure	1.26 (1.04, 1.52)	0.016	1.64 (1.11, 2.42)	0.014

Results of logistic regression analysis, covariates taken from Visit 2. BMI indicates body mass index; GFR, glomerular filtration rate; OR, odds ratio.